56 publications

Name Date Type Actions

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

 		24/04/2024 Reference document

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

 		24/04/2024 Reference document

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

 		12/09/2023 Half Year Report

2023 Half-Year Results

Contents
1.H1 2023 Highlights
2.H1 2023 Consolidatedfinancialstatements
3.Strategyand outlook

 		07/09/2023 Half Year Report

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

 		26/06/2023 Half Year Report

Universal registration document 2022

Universal Registration Document including the Annual Financial Report

 		05/05/2023 Reference document

Document d’enregistrement universel (URD) 2022 version XBRL

Document d'enregistrement universel 2022 incluant le rapport financier annuel

 		13/04/2023 Reference document

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

 		23/09/2022 Public releases , Half Year Report

2022 half-year results

This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022.

 		15/09/2022 Half Year Report

Universal registration document 2021

Universal Registration Document including the Annual Financial Report

 		05/05/2022 Reference document

[Video] Présentation des résultats semestriels 2022 - french

Présentation analystes & investisseurs - 15 septembre 2022

 		29/07/2021 Half Year Report

[VIDEO] Présentation des résultats semestriels 2021 - french

Présentation analystes & investisseurs - 29 juillet 2021

 		29/07/2021 Half Year Report

H1 2021 results

H1 2021 results

 		29/07/2021 Half Year Report

2021 Half year Financial Report (french)

Half year Financial Report (french version)

 		29/07/2021 Half Year Report

2020 Universal registration document

2020 universal registration document including the Annual Financial Report

 		28/04/2021 Reference document

Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.

 		08/02/2021 press release excluding results

2020 Half year Financial Report (french)

Half year Financial Report

 		31/07/2020 Half Year Report

[VIDEO] Présentation des résultats semestriels 2020 - french

 		31/07/2020 Half Year Report

H1 2020 results

H1 2020 Result

 

 		30/07/2020 Half Year Report

2019 Universal registration document

Note to recipient of this document: this is the translation of an extract of the Universal Registration Document and Annual Financial Report for the year ended December 31, 2019. The original French document was filed with the AMF (French Financial Markets Authority) on April 23, 2020.

 		23/04/2020 Reference document

[AUDIO] Présentation des résultats semestriels 2019 - french

Vetoquinol - 25.07.2019 - Enregistrement Audio Conference

 		26/07/2019 Half Year Report

2019 Half year Financial Report (french)

Half year Financial Report

 		25/07/2019 Half Year Report

H1 2019 RESULTS

H1 2019 results

 

 		25/07/2019 Half Year Report

2018 registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2018.

 		29/04/2019 Reference document

[AUDIO] Présentation des résultats semestriels 2018 - french

Vetoquinol - 26.07.2018 - Enregistrement Audio Conference

 		30/07/2018 Half Year Report

H1 2018 results presentation

Slideshow - July 26, 2018

 		26/07/2018 Half Year Report

2018 Half year Financial Report

2018 Half year Financial Report

 		26/07/2018 Half Year Report

2017 Registration document

2017 Registration document

 		23/04/2018 Reference document

2017 Half year Financial Report

2017 Half year Financial Report

 		27/07/2017 Half Year Report

H1 results presentation

Slideshow - July 27, 2017

 		27/07/2017 Half Year Report

2016 Registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2016. The original French document was filed with the AMF (French Financial Markets Authority) on April 26, 2017.

 		26/04/2017 Reference document

Présentation des résultats semestriels 2016 - french

Vétoquinol - 28.07.2016 - 18h15 - Enregistrement Audio Conference

 		29/07/2016 Half Year Report

2016 Half year Financial Report

Half year Financial Report

 		29/07/2016 Half Year Report

2016 first half results

2016 Half year results

 		28/07/2016 Half Year Report

2015 Registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2015. The original French document was filed with the AMF (French Financial Markets Authority) on April 26, 2016.

 		27/04/2016 Reference document

2015 First half Results

2015 Half year results

 		30/07/2015 Half Year Report

Half year Financial Report 2015

Half year Financial Report 2015

 		30/07/2015 Half Year Report

Registration Document 2014

Registration Document 2014

 		20/04/2015 Reference document

Rapport financier semestriel 2014 (french)

 		31/07/2014 Half Year Report

2014 First half Results

2014 Half year results

 		31/07/2014 Half Year Report

Reference Document 2013

Reference Document 2013

 		14/04/2014 Reference document

First half Results

2013 Half year results

 		09/09/2013 Half Year Report

Half year financial report 2013

2013 Half year Financial Report

 		30/08/2013 Half Year Report

Reference Document 2012 (in french)

Reference Document 2012 (in french)

 		16/04/2013 Reference document

Rapport financier semestriel 2012 (french)

> Rapport d’activité semestriel 2012
<br>> Etats financiers consolidés résumés au 30 juin 2012
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2012

 		06/09/2012 Half Year Report

First half Results

2012 Half year results

 		30/08/2012 Half Year Report

Reference document 2011

Reference document 2011

 		26/04/2012 Reference document

Rapport financier semestriel 2011 (french)

> Rapport d&rsquo;activité semestriel 2011
<br>> Etats financiers consolidés résumés au 30 juin 2011
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2011

 		01/09/2011 Half Year Report

2011 Half Year Results

2011 Half year results

 		31/08/2011 Half Year Report

Reference document 2010

Reference document 2010

 		27/04/2011 Reference document

Rapport financier semestriel 2010 (french)

1. Rapport d’activité semestriel 2010
<br>2. États financiers consolidés semestriels résumés au 30 juin 2010
<br>3. Attestation du responsable du document
<br>4. Rapport des Commissaires aux comptes sur l’information financière semestrielle 2010

 		01/09/2010 Half Year Report

Vétoquinol: H1 2009 interim earnings

1.‘Hybrid’ growth
<br>2.Stronginterimresults
<br>3.Focus on twostrategicpillars:
<br>- Innovation throughR&D
<br>- Potentialfor externalgrowth
<br>4.Questions and answers

 		31/08/2010 Half Year Report

Reference Document 2009

Reference Document 2009

 		23/04/2010 Reference document

2008 financial report

Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie.
<br>
Historiquement implanté sur le marché français, le groupe réalise désormais 78% de son chiffre d'affaires consolidé à l'international (234,4 millions d'euros en 2008). Les 1400 collaborateurs du Groupe se répartissent entre la Recherche & Développement, la production et la commercilisation.
<br>
Aujourd'hui, la PME française -11e acteur mondial en santé animale (hors aliments)- produit et distribue 700 médicaments et produits non médicamenteux dans près de 100 pays (Europe, Amérique du Nord et Asie). Elle s'appuie sur ses filiales dans 22 pays et sur un réseau de 140 partenaires distributeurs.

 		04/05/2009 Reference document

Financial report 2007

Consolidated 2007 figures are even better than the targets in the business plan we presented for the initial public offering (IPO) in November 2006.
<br>
Revenues rose by 10.3% to 233.4 million euros (211.6 million euros in 2006), including 7.6% organic growth.
<br>
The operating profit from continuing operations increased by 13.9%, from 25.6 million euros in 2006 to 29.2 million euros in 2007.
<br>
Finally, net profit increased by 17.8% to 18.6 million euros in 2007 (15.8 million euros in 2006), for a net margin of 8% (7.5% the previous year).

 		15/05/2008 Reference document

Etats financiers consolidés du 1er semestre 2007 (french)

 		27/09/2007 Half Year Report